Validation of Bevacizumab Therapy Effect on Colon Cancer Subtypes by Using Whole Body Imaging in Mice

Ivan Vuletic,Kedi Zhou,Hui Li,Huichen Bai,Xiangxi Meng,Sihao Zhu,Yichen Ding,Jun Li,Hongfang Sun,Qiushi Ren
DOI: https://doi.org/10.1007/s11307-017-1048-z
2017-01-01
Molecular Imaging and Biology
Abstract:Preclinical imaging offers a useful tool for monitoring cancer biological behavior and therapy in vivo without the necessity of animal surgery. The following paper describes our examination of tumor progress and anti-angiogenic therapy with Bevacizumab on colon cancer subtypes (SW480 and SW620) by using different non-invasive real-time in vivo imaging techniques.
What problem does this paper attempt to address?